212 related articles for article (PubMed ID: 18372103)
41. The CYP1A2-164A-->C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans.
Moonen H; Engels L; Kleinjans J; Kok Td
Cancer Lett; 2005 Nov; 229(1):25-31. PubMed ID: 16157215
[TBL] [Abstract][Full Text] [Related]
42. Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas.
Ishibe N; Sinha R; Hein DW; Kulldorff M; Strickland P; Fretland AJ; Chow WH; Kadlubar FF; Lang NP; Rothman N
Pharmacogenetics; 2002 Mar; 12(2):145-50. PubMed ID: 11875368
[TBL] [Abstract][Full Text] [Related]
43. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
Gu J; Liang D; Wang Y; Lu C; Wu X
Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
[TBL] [Abstract][Full Text] [Related]
44. Association of prostate cancer with rapid N-acetyltransferase 1 (NAT1*10) in combination with slow N-acetyltransferase 2 acetylator genotypes in a pilot case-control study.
Hein DW; Leff MA; Ishibe N; Sinha R; Frazier HA; Doll MA; Xiao GH; Weinrich MC; Caporaso NE
Environ Mol Mutagen; 2002; 40(3):161-7. PubMed ID: 12355549
[TBL] [Abstract][Full Text] [Related]
45. Lack of association between the polyadenylation polymorphism in the NAT1 (acetyltransferase 1) gene and colorectal adenomas.
Probst-Hensch NM; Haile RW; Li DS; Sakamoto GT; Louie AD; Lin BK; Frankl HD; Lee ER; Lin HJ
Carcinogenesis; 1996 Oct; 17(10):2125-9. PubMed ID: 8895478
[TBL] [Abstract][Full Text] [Related]
46. Meat consumption, cigarette smoking, and genetic susceptibility in the etiology of colorectal cancer: results from a Dutch prospective study.
Tiemersma EW; Kampman E; Bueno de Mesquita HB; Bunschoten A; van Schothorst EM; Kok FJ; Kromhout D
Cancer Causes Control; 2002 May; 13(4):383-93. PubMed ID: 12074508
[TBL] [Abstract][Full Text] [Related]
47. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
[TBL] [Abstract][Full Text] [Related]
48. NAT2, meat consumption and colorectal cancer incidence: an ecological study among 27 countries.
Ognjanovic S; Yamamoto J; Maskarinec G; Le Marchand L
Cancer Causes Control; 2006 Nov; 17(9):1175-82. PubMed ID: 17006723
[TBL] [Abstract][Full Text] [Related]
49. Meat consumption, N-acetyl transferase 1 and 2 polymorphism and risk of breast cancer in Danish postmenopausal women.
Egeberg R; Olsen A; Autrup H; Christensen J; Stripp C; Tetens I; Overvad K; Tjønneland A
Eur J Cancer Prev; 2008 Feb; 17(1):39-47. PubMed ID: 18090909
[TBL] [Abstract][Full Text] [Related]
50. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.
da Silva TD; Felipe AV; de Lima JM; Oshima CT; Forones NM
World J Gastroenterol; 2011 Feb; 17(6):760-5. PubMed ID: 21390146
[TBL] [Abstract][Full Text] [Related]
51. Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis.
Sanderson S; Salanti G; Higgins J
Am J Epidemiol; 2007 Oct; 166(7):741-51. PubMed ID: 17675654
[TBL] [Abstract][Full Text] [Related]
52. Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.
Gibson TM; Smedby KE; Skibola CF; Hein DW; Slager SL; de Sanjosé S; Vajdic CM; Zhang Y; Chiu BC; Wang SS; Hjalgrim H; Nieters A; Bracci PM; Kricker A; Zheng T; Kolar C; Cerhan JR; Darabi H; Becker N; Conde L; Holford TR; Weisenburger DD; De Roos AJ; Butterbach K; Riby J; Cozen W; Benavente Y; Palmers C; Holly EA; Sampson JN; Rothman N; Armstrong BK; Morton LM
Cancer Causes Control; 2013 Jan; 24(1):125-34. PubMed ID: 23160945
[TBL] [Abstract][Full Text] [Related]
53. Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.
Hou ZD; Xiao ZY; Gong Y; Zhang YP; Zeng QY
BMC Pharmacol Toxicol; 2014 Nov; 15():64. PubMed ID: 25413361
[TBL] [Abstract][Full Text] [Related]
54. Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma.
Kilfoy BA; Zheng T; Lan Q; Han X; Holford T; Hein DW; Qin Q; Leaderer B; Morton LM; Yeager M; Boyle P; Zhao P; Chanock S; Rothman N; Zhang Y
Cancer Causes Control; 2010 Jan; 21(1):127-33. PubMed ID: 19809881
[TBL] [Abstract][Full Text] [Related]
55. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma.
Katoh T; Boissy R; Nagata N; Kitagawa K; Kuroda Y; Itoh H; Kawamoto T; Bell DA
Int J Cancer; 2000 Jan; 85(1):46-9. PubMed ID: 10585581
[TBL] [Abstract][Full Text] [Related]
56. N-acetyltransferase polymorphisms are associated with risk of lymphoma subtypes.
Cocco P; Zucca M; Sanna S; Satta G; Nonne T; Angelucci E; Gabbas A; Rais M; Malpeli G; Campagna M; Scarpa A; G Ennas M
Hematol Oncol; 2016 Jun; 34(2):79-83. PubMed ID: 25689677
[TBL] [Abstract][Full Text] [Related]
57. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England.
Welfare MR; Cooper J; Bassendine MF; Daly AK
Carcinogenesis; 1997 Jul; 18(7):1351-4. PubMed ID: 9230278
[TBL] [Abstract][Full Text] [Related]
58. Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer.
Majumder M; Ghosh S; Roy B
Indian J Med Res; 2012 Oct; 136(4):605-13. PubMed ID: 23168701
[TBL] [Abstract][Full Text] [Related]
59. Smoking and risk of multiple sclerosis: evidence of modification by NAT1 variants.
Briggs FB; Acuna B; Shen L; Ramsay P; Quach H; Bernstein A; Bellesis KH; Kockum IS; Hedström AK; Alfredsson L; Olsson T; Schaefer C; Barcellos LF
Epidemiology; 2014 Jul; 25(4):605-14. PubMed ID: 24625537
[TBL] [Abstract][Full Text] [Related]
60. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
